Schonfeld Strategic Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Buy |
+15,929
| New | +$18.5K | ﹤0.01% | 1840 |
|
|
2024
Q3 | – | Sell |
-73,619
| Closed | -$178K | – | 1839 |
|
|
2024
Q2 | $178K | Sell |
73,619
-384,865
| -84% | -$931K | ﹤0.01% | 1690 |
|
|
2024
Q1 | $1.86M | Sell |
458,484
-103,058
| -18% | -$417K | 0.01% | 861 |
|
|
2023
Q4 | $2.16M | Sell |
561,542
-83,570
| -13% | -$321K | 0.01% | 714 |
|
|
2023
Q3 | $2.68M | Buy |
+645,112
| New | +$2.68M | 0.02% | 629 |
|
|
2022
Q4 | – | Sell |
-152,429
| Closed | -$1.53M | – | 2461 |
|
|
2022
Q3 | $1.53M | Buy |
152,429
+36,400
| +31% | +$365K | 0.01% | 996 |
|
|
2022
Q2 | $545K | Buy |
116,029
+29,486
| +34% | +$138K | 0.01% | 1247 |
|
|
2022
Q1 | $338K | Hold |
86,543
| – | – | ﹤0.01% | 1550 |
|
|
2021
Q4 | $585K | Buy |
+86,543
| New | +$585K | 0.01% | 1117 |
|